Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.7 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |